Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Crick news > Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Researchers at the Crick and GSK will extend their ongoing collaboration to advance the discovery of new drug targets in a £11.5million effort.
7 Apr 2021
United Kingdom
Crick news

To view this News Article

Similar stories

Do you know a second year undergraduate looking for hands-on research training? More...

Director of Academic Training, Sally Leevers, explains how and why we're making changes to our summer student training p… More...

Principal Group Leader Caetano Reis e Sousa explains why working with Apple Tree Partners on early stage discovery resea… More...

Director and Chief Executive of the Crick, Paul Nurse, has been selected to receive the Order of Merit, one of the UK's … More...

We're celebrating Black History Month 2022 with PRISM, the Crick's race equity network, by highlighting the diversity of… More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


This website is powered by
ToucanTech